Senate GOP leaders reportedly are crafting a revised version of the Graham-Cassidy bill to make it more attractive to Sen. Lisa Murkowski in terms of funding for Alaska. But the Senate parliamentarian could knock out its central feature.
If approved, the lone insurer's proposed double-digit rate decrease would be the first time the average rate has decreased under the current federal healthcare law in Alaska.
The CMS has approved a first of its kind waiver for Alaska that will allow federal money to create a high-risk fund. It will allow the state to continue trying to entice cash-strapped insurance companies to stay on the individual market in the state and not raise premiums.
When physicians burn out, solutions are elusive. Support groups can't counter the root causes of a crisis
Healthcare systems, practices and medical schools are deploying an array of tactics to help physicians cope with the unique stress of modern medicine. Some programs offer regular moments of reflection, connection with other doctors or other sources of catharsis.
Anxiety is rippling through the healthcare industry as the initial reporting period for Medicare's new payment system for physicians fast approaches. Modern Healthcare's latest CEO Power Panel survey reveals leaders are bracing for uncertainties and challenges generated by MACRA.
The American Hospital Association has warned the Affordable Care Act marketplaces lack stability as insurers exit and concern over drastically rising premiums continues.
Two new centers will study the impact of a person's surrounding environment—the family, local community, the healthcare system—on health, rather than homing in on individual factors.
More than a third of the Affordable Care Act's exchanges will have only one participating health insurer in 2017, significantly up from 4% reported this year, according to a recent analysis.
Tim Hingtgen has been names COO of Community Health Systems, effective Sept.1.
Colorado's legalization of cannabis for recreational use is associated with an increase in the number of young children who were treated for unintentional exposure to the drug, according to a study in JAMA Pediatrics.
The Food and Drug Administration has again delayed a rule requiring generic drug companies to update product labels if they receive new safety information.
Price and utilization are the two basic components of the nation's healthcare tab, and wild differences in prices for common medical procedures appear to be driving it up.